Scientists hunt for hidden signs of ALS and FTD in skin and tears
NCT ID NCT06856850
First seen Apr 07, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study aims to find biological markers (biosignatures) in people with ALS and FTD to make diagnosis more precise. Researchers will analyze samples like spinal fluid, skin, and tears from 230 participants using advanced techniques. The goal is to create a 'disease fingerprint' that helps doctors diagnose earlier and track how the disease progresses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHIATRIC DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero Universitaria di Sassari
NOT_YET_RECRUITINGSassari, 07100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Consorzio Interuniversitario Risonanze Magnetiche Metallo Proteine (CIRMMP)
NOT_YET_RECRUITINGSesto Fiorentino, 50019, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITINGMilan, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Università degli Studi di Napoli "Federico II"
NOT_YET_RECRUITINGNaples, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to better, earlier diagnosis of ALS and FTD and help track disease progression more accurately.
What could go wrong
This is an early-stage observational study, not a treatment trial. The biomarkers identified may not prove useful in real-world clinical settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.